Eli Lilly to Invest $1 Billion in New Contract Manufacturing Facility in Hyderabad.

Eli Lilly and Company announced plans to invest more than $1 billion over the next several years to establish a new contract manufacturing facility in Hyderabad, India. The investment marks a major step in expanding the company’s global manufacturing and quality capabilities.

The upcoming facility will serve as a hub for advanced technical operations and oversight of Lilly’s contract manufacturing network in India. It will also strengthen the company’s ability to supply medicines to patients worldwide.

Recruitment for the new site will begin immediately, with openings across various roles including engineers, chemists, analytical scientists, quality control and assurance experts, and management professionals.

“We are making significant investments to increase manufacturing and medicine supply capacity around the world to help ensure patients have access to the medicines they need,” said Patrik Jonsson, Executive Vice President and President, Lilly International, in a statement.